JPH085638A - Health care system - Google Patents

Abstract

PURPOSE:To promote health care in daily life by estimating the possibility of cancer crisis characteristic of female based on the quantity of female hormone and steroid hormone during a predetermined interval of ovarian cycle thereby awakening a user to the possibility of cancer crisis. CONSTITUTION:When a user sits on a toilet seat and urinates, a urine sensor 4 detects the urine. Based on a signal from the sensor 4, female hormone 5 and steroid hormone 6 are detected and stored 8. The ovarian cycle 15 then operated 9 based on the time series variation of female hormone thus stored and a decision is made at which interval of the ovarian cycle the detection day belongs. If the detection day substantially belongs to the first week after ovulation, the cancer crisis possibility estimatting means 10 receiving the signal 9 compares the values of both stored hormones with each other. The both hormones are also compared with a standard quantity and a possibility of cancer crisis is estimated based on the transition of variation rate of the compared value during a predetermined interval and the estimated possibility is displayed 13. The user comprehends the value and recognizes the possibility of cancer crisis thus promoting the daily health care.

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION The present invention estimates the risk rate of cancer (uterine cancer, breast cancer, ovarian cancer) peculiar to women, and is aware of the cancer risk rate in daily life. It is related to a health management system that promotes improvement and medical examinations to prevent cancer peculiar to women.

[0002]

2. Description of the Related Art As a conventional home health management system, there is a system in which a urine analyzer is installed and glucose, protein, urobilinogen, occult blood, etc. are measured at home (for example, USP 4,962,550, Japanese Patent Laid-Open No. Hei 6-55011). 5-228
116, JP-A-5-49603). However, these are important for the early detection of adult diseases such as diabetes, liver function, and kidney disease and the management of health status, but they are not effective for the prevention of cancer and health management peculiar to women.

Further, as a means for routinely detecting hormones to determine the state of the body, there is a method for determining pregnancy by detecting human chorionic gonadotropin (Japanese Patent Laid-Open No. HEI-2).
-107965, etc.). However, these also do not have means for estimating the cancer risk rate by detecting female hormones. In addition, except for those for determining pregnancy, the detection of hormones is left to the medical institutions, and there is no system for estimating the risk rate of cancer development from the above causal relationship.

[0004]

[Problems to be Solved by the Invention] For cancer peculiar to women,
Local governments also recommend annual cancer screening for women over the age of 30 who have breast cancer and uterine cancer. Breast cancer is increasing with increasing intake of animal fat, and uterine cancer is also decreasing, but it still occupies the upper rank of cancer in women, and primary prevention of cancer peculiar to women is desired. However, there is no technology to estimate the risk rate of cancer development in daily life as a primary prevention other than screening as a secondary prevention, and it is difficult and practically difficult to keep an eye on diet and daily life in a healthy state. there were.

Female hormones mainly include estrogen and luteinizing hormone, and the amount secreted changes depending on the ovarian cycle. Therefore, when grasping changes in hormone levels, it was necessary to always consider the influence of the ovarian cycle depending on the detection time.

The present invention is intended to solve the above problems,
Estimating the risk of cancer development from the relationship between female hormones and steroid hormones during a given period of the ovarian cycle in women eliminates the effects of changes in hormone secretion due to the ovarian cycle and is suitable for hormone detection under the same conditions each time. A health management device that promotes health management by detecting hormones at the time of secretion and effectively estimating the cancer risk rate and making the user aware of the cancer risk rate in daily life. This is the first purpose.

The second purpose is the age of the user, the experience of childbirth,
The purpose of the present invention is to provide a health management system that can more effectively estimate the risk rate of cancer development by inputting personal information related to female-specific cancer such as eating habits.

A third object is to provide a health management system which is convenient for the user in daily life by automatically detecting female hormones and steroid hormones in urine.

[0009]

To achieve the above object, the health management system of the present invention comprises a female hormone detecting means for detecting a female hormone, a steroid hormone detecting means for detecting a steroid hormone, and the female hormone detecting means. , And a hormone signal storage means for storing the output signal of the steroid hormone detection means in time series, an ovarian cycle calculation means for calculating an ovarian cycle from the change of the female hormone amount stored in the hormone signal storage means, and an ovarian cycle. Of the risk factors for cancer onset that calculates and estimates the risk factors for cancer peculiar to women from the amounts of female hormones and steroid hormones at a predetermined time in And a display means for displaying the contents stored in the cancer risk rate storage means. Only to those that you configured.

In order to achieve the second object, the health management system of the present invention is a personal information input means which is presumed to be related to cancer development peculiar to a woman, such as age of a user, experience of childbirth, eating habits. Is provided.

In order to achieve the third object, the health management system of the present invention is capable of detecting hormones that can be detected from urine excreted in daily life so that the user does not need to pay special attention for hormone detection. It is configured by providing means.

[0012]

The health management system of the present invention detects female hormones and steroid hormones according to the above configuration, first detects the ovarian cycle from changes in female hormones, and then determines the relative difference between female hormones and steroid hormones at a predetermined time within the ovarian cycle. And, since the risk of cancer development in a woman is estimated from the balance, the user can grasp the risk of cancer development in each predetermined ovarian cycle. In addition, since the measurement is performed at a predetermined time within the ovarian cycle, it is possible to eliminate the influence of changes in female hormone secretion during the ovarian cycle and to detect hormones under conditions suitable for hormone detection, which is an effective risk of cancer development. Rate estimation is possible. Further, the estimated cancer risk rate is displayed for each predetermined ovarian cycle, and the user can be aware of the cancer risk rate almost regularly, so that it is not necessary to pay attention to the examination time.

Secondly, the health management system of the present invention uses personal information input means to input information that is said to be related to the onset of cancer such as age, childbirth experience, eating habits, etc. Since it is used for estimating the risk of developing cancer, it is possible to estimate the risk of developing cancer more effectively.

Thirdly, since the hormone detecting means of the health management system of the present invention automatically detects the hormone from the urine at the time of urination, the operability is improved because it does not require time and labor for each inspection at home. To do.

[0015]

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to FIG.

FIG. 1 is a block diagram of a health management system showing an embodiment of the present invention, in which 1 is a toilet seat device attached to a toilet bowl 2, which is a cleaning means for cleaning a human body part, a drying means, and a toilet seat heating. It has a means etc. (not shown). Reference numeral 3 denotes a hormone detecting section, which is composed of a female hormone detecting means 5 for detecting a female hormone from a signal of the urine sensor 4 and a steroid hormone detecting means 6 for detecting a steroid hormone from a signal of the urine sensor 4, and is associated with urination. Works. Reference numeral 7 denotes an arithmetic circuit, which stores a hormone signal from the hormone detection unit 3 in time series, a hormone signal storage means 8, and a time series change of a female hormone signal stored in the hormone signal storage means 8 for a predetermined period from an ovarian cycle. Of the output signals stored in the ovarian cycle calculation means 9 for calculating the ovarian cycle calculation means 9, the female hormone and the steroid hormone after a predetermined date from the ovulation period in the ovarian cycle grasped by the ovarian cycle calculation means 9 It is composed of a cancer onset risk rate estimation calculation means 10 for estimating the cancer onset risk rate from the value of, and a cancer onset risk rate storage means 11 for storing the output result of the cancer onset risk rate estimation calculation means 10. Reference numeral 12 is a personal information input means for inputting information that is said to be related to cancer development, such as the user's age, childbirth experience, eating habits, and the cancer onset risk rate calculation means 10 is the personal information input means 12 The cancer risk rate is estimated based on the information obtained from and the levels of female hormones and steroid hormones. Reference numeral 13 denotes an operation display unit having a display screen, which is configured to display the stored contents of the cancer risk risk storage unit 11 and to operate the cleaning unit, the drying unit, the toilet seat heating unit, and the health management system on the display screen. Has been done.

Next, the operation and operation of this embodiment having the above structure will be described. When the user sits down on the toilet seat device 1, a personal identification screen of the user is displayed on the display screen of the operation display means 13, and the user personally identifies by selecting and operating the display screen. When the user urinates, the urine sensor 4 automatically operates to perform urine test. The female hormone detecting means 5 detects a female hormone from the signal of the urine sensor 4, and the detected female hormone is stored in the hormone signal storage means 8. On the other hand, the steroid hormone detecting means 6 detects the steroid hormone from the signal of the urine sensor 4 and stores it in the hormone signal storing means 8. The ovarian cycle calculating means 9 calculates the ovarian cycle from the time-series change of the female hormone stored in the hormone signal storage means 8 to determine which time of the ovarian cycle the detection date corresponds to.

Female hormones include estrogen and luteinizing hormone, but the amount secreted differs depending on the ovarian cycle. Figure 2
Shows changes in the amount of estrogen and luteinizing hormone secreted during the ovarian cycle. Erythrone increases rapidly before the ovulatory phase, and luteinizing hormone is secreted when ovulating. When pregnancy is not established, estrogen and luteinizing hormone decrease as the luteal body recedes, leading to the onset of menstruation. Therefore, when estimating the risk of cancer development from the tendency to secrete female hormones and steroid hormones, the ovarian cycle may have a large effect. In the ovarian cycle, both estrogen and luteinizing hormone levels are appropriately secreted about one week after ovulation. Therefore, if it is detected at this time, it is easy to compare the hormone amounts. Therefore, when the detection date corresponds to a predetermined date after the internal ovulation cycle of the ovarian cycle, that is, about one week after the ovulation, the cancer risk estimating rate calculating means 10 receives a signal from the ovarian cycle calculating means 9. The female and steroid hormone values stored in the hormone signal storage means 8 are relatively compared with each other, and the female and steroid hormones and the respective standard predetermined amounts are compared and calculated. The cancer onset risk rate estimation calculation is performed according to the change rate transition. Female hormones are mainly estrogen and luteinizing hormone. Among hormones detected in urine, breast cancer patients have high steroid hormones and low luteinizing hormones, and uterine cancer patients have high estrogen hormones and low steroids. Also, patients with ovarian cancer tend to have low levels of both female and steroid hormones.

That is, the calculation result of the cancer risk estimating rate calculating means 10 shows that the breast cancer risk rate is high and the female hormone internal follicle hormone is high when the steroid hormone is high and the female progesterone is low in the progesterone for a predetermined period. The uterine cancer incidence is low when steroid hormones are low, and the ovarian cancer risk is high when both female and steroid hormones are low.

Breast cancer has increased remarkably in recent years, and uterine cancer has tended to decrease, but remains a high cause of death. It is said that the incidence of breast cancer is increased by consuming a large amount of animal fat in the diet, and it is also said that cervical cancer is high in women who have a large number of births and uterine body cancer is large in women who have a small number of births. Various factors such as eating habits, stress, and experience of childbirth affect the hormonal environment and are associated with cancer development in women. Therefore, the personal information such as age, childbirth experience, eating habits, etc., input to the personal information input means 12 is input to the cancer risk estimating rate calculating means 10 together with the output signals of the female hormone detecting means 5 and the steroid hormone detecting means 6. An estimation calculation is performed.

Estimated cancer risk rate estimation calculation means 1
The output result of 0 is displayed on the display screen of the operation display unit 13, and the user can grasp the estimated cancer risk ratio. Therefore, the user can promote health management by being aware of the risk of developing cancer every day from the ovulation period to a predetermined date, and being aware of improvement in daily life.

As described above, in this embodiment, the toilet seat device 1 attached to the toilet 2 is provided with the urine sensor 4, and the female hormone detecting means 5 and the steroid hormone detecting means 6 are used as hormones from the signals of the urine sensor 4. Since the detection is performed, the user can detect the hormone from the urine at the time of daily urination, and can easily detect the hormone in daily life without performing complicated work.

Further, the risk of cancer development is estimated and calculated from the values of female hormones and steroid hormones in the ovarian cycle grasped by the ovarian cycle calculation means 9 after a predetermined date from the ovulation period. Since the hormone status at a certain time is compared, the influence of changes in the secretion amount due to the ovarian cycle is eliminated, and by detecting the hormone at the optimum secretion time for the comparison calculation, the cancer risk rate is effectively Estimative calculations can be performed.

Further, a personal information input means 12 is provided so that personal information which is said to be related to the onset of cancer, such as the user's age, birth experience, and eating habits, can be input. The risk of cancer risk estimation is calculated from the signal from the personal information input means 12 and the values of female hormones and steroid hormones stored in the hormone signal storage means 8. Therefore, the risk of cancer risk estimation can be estimated more effectively. It will be possible.

[0025]

As described above, since the health management system of the present invention is provided with the cancer development risk rate estimation calculation means for estimating the cancer development risk rate peculiar to women, it is possible for women to develop cancer. It is possible to promote the primary prevention of cancer, which is said to be important for health management in daily life, by being able to continuously understand the risk of illness and being aware of the need for life improvement.

Further, the health management system of the present invention comprises an ovarian cycle calculating means for calculating the ovarian cycle from the output result of the female hormone detecting means, and the cancer risk estimating rate calculating means is the ovarian cycle. The risk of cancer development is estimated and calculated from the values of female hormones and steroid hormones after a predetermined date from the internal ovulation period of the ovarian cycle determined by the calculation means. This makes it possible to calculate the risk of cancer risk estimation from the hormone state at a certain time in each ovarian cycle, eliminating the influence of changes in the secretory amount due to the ovarian cycle and determining the optimal secretory amount for comparison calculation. By detecting hormones at a certain time, it is possible to carry out an effective calculation for estimating the risk of developing cancer.

Since the health management system of the present invention comprises personal information input means for inputting personal information that is said to be related to the onset of cancer, such as the age of the user, experience of childbirth, eating habits, etc., The cancer onset risk estimation calculation means can estimate the cancer onset risk rate from the information from the personal information input means and the values of female hormones and steroid hormones, and more effectively estimate the cancer onset risk rate. be able to.

Further, since the health management system of the present invention automatically detects female hormones and steroid hormones from the urine during urination, it does not require complicated work for hormone detection and can be used in daily life. It is easy to use and you can continuously manage your health.

[Brief description of drawings]

FIG. 1 is a configuration diagram of a health management device showing an embodiment of the present invention.

FIG. 2 is a diagram showing changes in female hormones (ovarian hormones and luteinizing hormones) during the ovarian cycle.

[Explanation of symbols]

 DESCRIPTION OF SYMBOLS 1 Toilet seat device 2 Toilet bowl 3 Hormone detection part 4 Urine sensor 5 Female hormone detection means 6 Steroid hormone detection means 7 Arithmetic circuit 8 Hormone signal memory means 9 Ovarian cycle arithmetic means 10 Cancer onset risk rate estimation arithmetic means 11 Cancer onset risk rate Storage means 12 Personal information input means 13 Operation display means

Claims (3)

[Claims] 1. A female hormone detecting means for detecting a female hormone, a steroid hormone detecting means for detecting a steroid hormone, and a hormone signal memory for storing output signals of the female hormone detecting means and the steroid hormone detecting means in time series. And an ovarian cycle calculating means for calculating an ovarian cycle from a change in the amount of female hormone stored in the hormone signal storage means, and a risk of developing a cancer peculiar to a woman from the amount of female hormone and steroid hormone at a predetermined time of the ovarian cycle Cancer onset risk rate estimation calculation means for estimating and calculating the rate, cancer development risk rate storage means for storing the output result of the cancer development risk rate estimation calculation means in time series, and cancer development risk rate storage means Health management system with display means for displaying the memory contents of. 2. The health management system according to claim 1, further comprising personal information input means for inputting personal information relating to cancer development such as an individual's age, birth experience, and eating habits. 3. The health management system according to claim 1, wherein the hormone detecting means is configured to detect a female hormone and a steroid hormone by the output of a urine sensor provided in the toilet bowl.